Published in J Vestib Res on February 02, 1999
Changes in protein expression in the rat medial vestibular nuclei during vestibular compensation. J Physiol (2006) 0.84
The response of vestibulo-ocular reflex pathways to electrical stimulation after canal plugging. Exp Brain Res (2003) 0.80
Spatial coding capacity of central otolith neurons. Exp Brain Res (2006) 0.75
Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci (2001) 3.85
Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development (1996) 3.84
Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev (2001) 3.67
Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci (1997) 3.41
IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron (1997) 3.21
Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev (2001) 2.96
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol (2001) 2.88
The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev (1999) 2.78
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med (1999) 2.78
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci (1998) 2.28
Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet. Kidney Int (2006) 2.22
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J Biol Chem (2001) 1.94
Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci (1997) 1.84
Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A (2001) 1.84
Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev (1995) 1.81
Neuroprotective effects of adenosine. Trends Pharmacol Sci (1988) 1.69
The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev (1998) 1.64
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience (2000) 1.55
The role of immediate early genes in the stabilization of long-term potentiation. Mol Neurobiol (1991) 1.41
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun (1992) 1.39
Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol (1997) 1.35
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther (2001) 1.34
Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature (1993) 1.33
APC truncation and increased beta-catenin levels in a human breast cancer cell line. Carcinogenesis (2000) 1.32
Selective dependence of mammalian dorsal root ganglion neurons on nerve growth factor during embryonic development. Neuron (1992) 1.30
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene (2011) 1.30
Correlations between immediate early gene induction and the persistence of long-term potentiation. Neuroscience (1993) 1.26
CREB phosphorylation promotes nerve cell survival. J Neurochem (1999) 1.24
In vitro endothelial potential of human UC blood-derived mesenchymal stem cells. Cytotherapy (2006) 1.23
A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience (1999) 1.22
Complex, two-way traffic of molecules across the membrane of the endoplasmic reticulum. J Biol Chem (1998) 1.21
The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience (2005) 1.21
Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res (1995) 1.20
Expression of a novel protocadherin, OL-protocadherin, in a subset of functional systems of the developing mouse brain. J Neurosci (1999) 1.17
An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience (1999) 1.17
A role for the TFIIH XPB DNA helicase in promoter escape by RNA polymerase II. J Biol Chem (1999) 1.14
Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction. J Neurosci (2001) 1.13
Axotomy-induced neuronal death during development. J Neurobiol (1992) 1.13
Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog Neurobiol (1999) 1.13
The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol (1996) 1.12
Simulation of phase transitions in fluids. Annu Rev Phys Chem (1999) 1.09
Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res (1998) 1.09
Polarization-driven topological insulator transition in a GaN/InN/GaN quantum well. Phys Rev Lett (2012) 1.08
Axotomy results in major changes in BDNF expression by dorsal root ganglion cells: BDNF expression in large trkB and trkC cells, in pericellular baskets, and in projections to deep dorsal horn and dorsal column nuclei. Eur J Neurosci (1999) 1.06
Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. Neuroscience (2001) 1.06
Occurrence of ammonia-oxidizing Archaea in activated sludges of a laboratory scale reactor and two wastewater treatment plants. J Appl Microbiol (2009) 1.06
Retinal pigment epithelial wound healing in vivo. Arch Ophthalmol (1995) 1.05
Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport (1999) 1.05
Transcription factors TFIIF, ELL, and Elongin negatively regulate SII-induced nascent transcript cleavage by non-arrested RNA polymerase II elongation intermediates. J Biol Chem (2001) 1.05
Vestibular-hippocampal interactions. Hippocampus (1997) 1.05
Endogenous brain-derived neurotrophic factor and neurotrophin-3 antagonistically regulate survival of axotomized corticospinal neurons in vivo. J Neurosci (2001) 1.04
Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities. Oncogene (2006) 1.04
Effects of early visual experience and diurnal rhythms on BDNF mRNA and protein levels in the visual system, hippocampus, and cerebellum. J Neurosci (2001) 1.04
Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina. Exp Neurol (1991) 1.03
Doublecortin expression in the normal and epileptic adult human brain. Eur J Neurosci (2008) 1.02
Is adenosine an endogenous anticonvulsant? Epilepsia (1985) 1.02
Estradiol, progesterone and testosterone exposures affect the atrial natriuretic peptide gene expression in vivo in rats. Biol Chem Hoppe Seyler (1992) 1.02
The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair. Brain Res Mol Brain Res (1996) 1.02
Rapid alterations of BDNF protein levels in the rat brain after focal ischemia: evidence for increased synthesis and anterograde axonal transport. Exp Neurol (1998) 1.02
Correlation between the induction of an immediate early gene, zif/268, and long-term potentiation in the dentate gyrus. Brain Res (1992) 1.01
Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum. Neuroscience (1998) 1.01
Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res (1996) 1.00
Krox20 may play a key role in the stabilization of long-term potentiation. Brain Res Mol Brain Res (1995) 0.99
Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect (2013) 0.99
Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res Brain Res Rev (1999) 0.99
Biotransformation of Panax notoginseng saponins into ginsenoside compound K production by Paecilomyces bainier sp. 229. J Appl Microbiol (2007) 0.97
Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study. Neuroscience (1990) 0.96
Static magnetic field effects on bone formation of rats with an ischemic bone model. Biomed Mater Eng (2001) 0.96
Q vectors, bicistronic retroviral vectors for gene transfer. Biotechniques (2000) 0.95
αA- and αB-crystallins interact with caspase-3 and Bax to guard mouse lens development. Curr Mol Med (2012) 0.95
The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs. Prog Neurobiol (1996) 0.94
First human hNT neurons patterned on parylene-C/silicon dioxide substrates: Combining an accessible cell line and robust patterning technology for the study of the pathological adult human brain. J Neurosci Methods (2010) 0.93
Neurochemical and morphological changes associated with human epilepsy. Brain Res Brain Res Rev (1995) 0.92
The yeast ALG11 gene specifies addition of the terminal alpha 1,2-Man to the Man5GlcNAc2-PP-dolichol N-glycosylation intermediate formed on the cytosolic side of the endoplasmic reticulum. J Biol Chem (2001) 0.92
Loss of Ref-1 protein expression precedes DNA fragmentation in apoptotic neurons. Brain Res Mol Brain Res (1997) 0.91
Expression and estrogen regulation of brain-derived neurotrophic factor gene and protein in the forebrain of female prairie voles. J Comp Neurol (2001) 0.91
Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Brain Res Mol Brain Res (1993) 0.91
The survival-promoting effect of glial cell line-derived neurotrophic factor on axotomized corticospinal neurons in vivo is mediated by an endogenous brain-derived neurotrophic factor mechanism. J Neurosci (1998) 0.91
Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. Neuroreport (1994) 0.91
The endogenous survival promotion of axotomized rat corticospinal neurons by brain-derived neurotrophic factor is mediated via paracrine, rather than autocrine mechanisms. Neurosci Lett (2000) 0.90
Valproic acid enhances microglial phagocytosis of amyloid-beta(1-42). Neuroscience (2010) 0.90
Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res (1997) 0.89
Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord. Neurosci Lett (1990) 0.89
Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience (1993) 0.89
A quantitative study of the developmental expression of nerve growth factor (NGF) receptor in rats. Dev Biol (1987) 0.89
Successful organ donation from brain dead donors in a Chinese organ transplantation center. Am J Transplant (2011) 0.89
Protocadherin 2C: a new member of the protocadherin 2 subfamily expressed in a redundant manner with OL-protocadherin in the developing brain. Biochem Biophys Res Commun (1999) 0.89
Pegylated brain-derived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury. Exp Neurol (2001) 0.89
GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiographic and immunohistochemical study at the light and electron microscopic levels. Neuroscience (1990) 0.89
Immediate early gene expression associated with the persistence of heterosynaptic long-term depression in the hippocampus. Proc Natl Acad Sci U S A (1994) 0.88
Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease. Br J Pharmacol (2010) 0.88
NGF and NT-3 have differing effects on the growth of dorsal root axons in developing mammalian spinal cord. J Neurosci (1994) 0.88
The toxicity of 6-hydroxydopamine on PC12 and P19 cells. Brain Res Mol Brain Res (1999) 0.88
Trk receptor alterations in Alzheimer's disease. Brain Res Mol Brain Res (1996) 0.88
Comparative study on gastrointestinal microbiota of eight fish species with different feeding habits. J Appl Microbiol (2014) 0.88
L-dopa activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur J Pharmacol (1989) 0.87
Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res Mol Brain Res (1994) 0.87